UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported)July 8, 2007 ZILA, INC.
(Exact Name of Registrant as Specified in Charter)
| | | | | |
| Delaware | | 0-17521 | | 86-0619668 |
| | | | | |
(State or Other Jurisdiction
of Incorporation) | | (Commission File
Number) | | (I.R.S. Employer
Identification No.) |
5227 North 7th Street, Phoenix, Arizona 85014-2800
(Address of Principal Executive Offices)
(602) 266-6700
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (seeGeneral Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
| | |
| Item 5.02. | | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On July 8, 2007, David Sidransky, MD, informed Zila, Inc. (the “Company”) that he will resign from the Company’s Board of Directors (the “Board”) effective August 1, 2007. Dr. Sidransky did not resign from the Board because of a disagreement with the Company known to any executive officer of the Company on any matter relating to the Company’s operations, policies or practices. Dr. Sidransky will remain a member of the Company’s Medical Advisory Board.
A copy of the press release announcing, among other things, Dr. Sidransky’s resignation is attached hereto as Exhibit 99.1 and is incorporated herein by this reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| | | |
| Exhibit No. | | Description |
| |
| 99.1 | | Press release, dated July 10, 2007, entitled “Zila Executive and Board Chairman Acquire Stock” |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: July 11, 2007
| | | | | |
| | | ZILA, INC. |
| | | | | |
| | | /s/ | | Gary V. Klinefelter |
| | | |
| | | By: | | Gary V. Klinefelter |
| | | | | Vice President and General Counsel |
Exhibit Index
| | | |
| Exhibit No. | | Description |
| |
| 99.1 | | Press release, dated July 10, 2007, entitled “Zila Executive and Board Chairman Acquire Stock” |
